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1. Introduction 
Autism Spectrum Disorders (ASDs), which consist of Autistic Disorder, Asperger Syndrome 
and PDD Not Otherwise Specified (PDD-NOS), are subsets of Pervasive Developmental 
Disorders (PDD) (1, 2). Obviously, ASDs are characterized by abnormalities in social 
interaction and communication, as well as repetitive and stereotyped behaviors (3).  
Although various studies have been conducted in ASDs etiology across the world, it seems 
that they are still unknown in developing and developed countries. In fact, ASDs have been 
introduced as multifactorial disorders;  from ascendancy of genetic to environmental factors 
are involved in causing them (4-7).  
Although there are substantial biological bases for ASDs, no perspicuous symptoms exist for 
their diagnostic conditions. Therefore, behavioral criteria are mainly utilized to identify 
individuals with ASDs. Some assessment instruments are Autism Diagnostic Interview- 
Revised (ADI- R), Autism Diagnostic Observation Schedule (ADOS), Childhood Autism 
Rating Scale (CARS), Diagnostic Interview for Social and Communicative Disorders 
(DISCO), Developmental, Dimensional and Diagnostic Interview (3di), Autism Spectrum 
Disorders-Diagnostic for Children (ASD-DC), Autism Spectrum Disorders-Comorbidity for 
Children (ASD-CC) and Autism Spectrum Disorders-Behavior Problem for Children (ASD-
BPC) (8-15). There is universal agreement in diagnostic criteria of ASDs; however, the 
cultural differences influence their diagnosis (16).    
With regards to obscure etiology of ASDs, they have not been specifically treated up to now. 
Nevertheless, several treatments have been performed to improve ASDs including behavioral, 
medical, biological, sensory- motor and relationship development interventions (17-21).  
Whereas cultural factors play an essential role in prevalence, diagnosis and treatment of 
ASDs, cross-cultural studies should be performed (22-24). Hence, some scientific 
researches have been conducted on ASDs in Iran. Several preliminary investigations have 
been done to evaluate ASDs prevalence and some risk factors and effective variables have 
also been studied in the field of etiology. Diagnostic evaluation of ASDs, especially based 
on EEG, and several pharmacological and behavioral interventions for ASDs treatment 
have been performed in Iran. In parental studies, mental health, stress levels and 
personality characteristics were investigated in parents of children with ASDs, with focus 
on mothers.   
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A systematic literature review was performed to identify the ASDs studies in Iran. 
Accordingly, PubMed, ISI web of Science, and four Iranian databases, including 
IranPsych, IranMedex, Irandoc and Scientific Information Database (SID) were searched 
to find Iranian studies in ASDs using combination of two groups of terms. The first 
group included the following terms: Autism Spectrum Disorders, Autism, Autistic 
disorder, PDD Not Otherwise Specified and Asperger, combined with OR; and the 
second group consisted of Iran or its major cities. The name of famous Iranian 
researchers in ASDs field and their curriculum vitae were also searched to find scientific 
studies on ASDs in Iran. Case reports were excluded. The results of 39 investigations 
including the original, review, editorial material and proceedings articles and available 
dissertations were separately assigned to prevalence, etiology, diagnosis and treatment 
divisions.   
2. ASDs prevalence 
Less attention has been paid to studying ASDs -especially about their epidemiology- in 
developing countries. In fact, most studies about ASDs prevalence have been done in the 
United States and Europe (25). Overall, recent scientific researches indicated more rates of 
ASDs. The study of ASDs prevalence in primary school children estimated the rate of 157 
per 10,000 children in the United Kingdom (26). The only investigation on adults with 
ASDs evaluated the prevalence of these disorders to be 98 per 10,000 in England (27). 
Another study on 8 year-old children with ASDs estimated an average rate of 90 per 
10,000 participants in the United States (28). In a comprehensive review article, the 
prevalence rate was around 20 per 10,000 for Autistic disorder, 30 per 10,000 for PDD-
NOS, and 2 per 100,000 for Asperger syndrome (29). However, the rates of Asperger 
syndrome were estimated to be 36 out of 10,000 and 48 per 10,000 children in Sweden (30, 
31). There were various results about ASDs prevalence across the world. Accordingly, 
diversity among prevalence estimations could be related to the age of participants, 
diagnostic criteria, and geographical locations.. In addition, less prevalence of ASDs can 
be explained by the less available services and lack of awareness about ASDs in 
developing countries (32).              
While no advanced study have been conducted on the prevalence of ASDs in Iran (33), 
Ghanizadeh` s preliminary investigation on school children (2008) indicated the rate of 19 
per 1000 for probable autistic disorder ,and 5 per 1000 for probable Asperger syndrome, 
which seem more than reported estimations of ASDs prevalence across the world (34). Also, 
Nejatisafa (2003) performed the first preliminary study to investigate the frequency of ASDs 
in university students ; while the scores were significantly higher for men than women, the 
results showed the frequency of 120 out of 1000 adult participants (35).  
Another study showed the highest prevalence rate of ASDs for autistic disorder, then 
Asperger syndrome and PDD-NOS. It also indicated that boys were 4 times more likely than 
girls to have autistic and Asperger disorders (36). The prevalence rates of autistic students 
have been displayed 0.366% among exceptional students (37).  
3. Etiology of ASDs  
ASDs have multiple etiologies; genetic polymorphisms, epigenetics, convergent molecular 
abnormalities, mutations, chromosomal aberrations, disorders in mirror neuron system and 
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central coherence, brain structure anomalies, cytogenetic abnormalities, and single-gene 
defects, toxic exposures, teratogens, measles-mumps-rubella vaccines, some prenatal, 
obstetric and neonatal factors and etc have been specified as the contributing factors in the 
etiologies of ASDs in the different researches across the world (7, 38-44). 
The relationships between ASDs and some effective factors have been investigated in Iran. 
In a   recent study, the theory of mind development was significantly affected by gender and 
IQ. so low functioning autistic children had the poorest performance in the theory of mind 
development compared to high functioning autistic children and normal group (45). In one 
study, IQ variable was an important factor to determine visual memory of meaningless 
shapes in children with ASDs. While a significant difference was observed in visual memory 
of meaningless shapes between children with ASDs and normal group by entering the IQ 
effect, the results were contradictory as the association was inversed by removing IQ. 
However, IQ variable was not correlated to face memory in children with ASDs. Overall, 
there was no significant difference in face memory between children with ASDs and normal 
group in this study (46).  
In a clinical study, no significant correlation was observed between gender and age, 
diagnosis and severity of the symptoms in children with ASDs (47).      
Sasanfar (2010) investigated the parental age and education level as risk factors and 
indicated that higher paternal age, but not maternal age, and higher education level 
increased the risk of autism. However, it seems that parents with high education usually 
seek the diagnostic and therapeutic services more than less educated parents (48).        
In another Iranian study, no correlation was observed between autism and Celiac diseases in 
autistic children compared to age and sex matched normal group (49).   
Since brain stem has a critical role in processing hearing inputs, its hearing function has 
been investigated by an auditory brain stem response tool in children with slight and severe 
autism compared to normal group. This research demonstrates brain stem abnormality in 
severe autistic children which may result in intensifying autism symptoms (50).  
Social interaction and stereotyped behaviors were investigated between autistic and 
trainable mentally retarded children. The results showed higher mean scores of qualitative 
damage to social interaction and stereotyped behaviors in autistic children compared to 
trainable mentally retarded children (51).  
4. Diagnosis of ASDs by EEG 
Several studies have been administered to diagnose abnormalities using quantitative 
electroencephalography (qEEG) analysis in children with ASDs compared with normal 
children. Considering that the relaxed eye-opened condition in alpha band was the best 
condition to discriminate between children with ASDs and normal group, the ASDs had 
significant lower spectrogram criteria values (p<0.01) at Fp1, Fp2, F3 and T5 electrodes and 
lower values (p<0.05) at T3, P3 and O1 electrodes. Accordingly, spectrogram criteria had 
displayed more abnormalities in the left brain hemisphere and prefrontal lobe in children 
with ASDs compared to normal children (52).  
Moreover, Magnitude Squared Coherence values at 171 pairs of EEG electrodes in the 
relaxed eye-opened condition illustrated more abnormalities in the connectivity of temporal 
lobes with other lobes in gamma frequency band in children with ASDs (54).   
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(From: Niedermeyer E, Lopes da Silva F. Electroencephalography: Basic principles, clinical applications, 
and related fields, 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2005, p 140) (53) 
Fig. 1. International EEG electrodes placement system 
 
Electrodes 
ASD children 
(Mean±SD) 
Control children 
(Mean±SD) 
p 
Fp1* 0.238±0.156 0.381±0.131 0.018 
Fp2 0.256±0.165 0.357±0.157 0.122 
F7* 0.245±0.131 0.376±0.146 0.021 
F3** 0.197±0.076 0.442±0.103 0.000 
Fz 0.237±0.106 0.309±0.175 0.192 
F4 0.270±0.174 0.309±0.137 0.529 
F8 0.300±0.198 0.337±0.118 0.583 
T3** 0.254±0.136 0.405±0.130 0.007 
C3* 0.251±0.156 0.401±0.121 0.013 
Cz* 0.267±0.146 0.407±0.173 0.030 
C4 0.291±0.182 0.310±0.190 0.796 
T4 0.313±0.175 0.391±0.219 0.308 
T5* 0.238±0.156 0.396±0.150 0.014 
P3 0.300±0.154 0.411±0.133 0.063 
Pz 0.310±0.196 0.395±0.147 0.231 
P4 0.340±0.194 0.407±0.179 0.373 
T6 0.319±0.170 0.388±0.123 0.258 
O1 0.304±0.169 0.381±0.151 0.234 
O2 0.308±0.161 0.293±0.163 0.821 
** p<0.01 and * p<0.05 
(From: Sheikhani A, Behnam H, Mohammadi MR, Noroozian M, Mohammadi M. Detection of 
Abnormalities for Diagnosing of Children with Autism Disorders Using of Quantitative 
Electroencephalography Analysis. J Med Syst 2010) (54) 
Table 1. The spectrogram criteria values of the EEG for the children with autism spectrum 
disorder (ASD) and control children for all electrodes in alpha band (8–13 Hz) 
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Notably, one research presented the gamma frequency band as the best discriminant in 
children with Asperger compared to normal group. Children with Asperger disorder had 
significant lower spectrogram criteria values (p<0.01) at Fp1 electrode and lower values 
(p<0.05) at Fp2 and T6 electrodes. Coherence values at 171 pairs of EEG electrodes 
displayed the connectivity at (T4, P4), (T4, Cz), (T4, C4) electrode pairs and (T4, O1) had 
significant differences (p<0.01) in the two groups in the gamma band. Accordingly, the 
prefrontal and right temporal lobes had more abnormalities based on using spectrogram, 
and coherence values showed more abnormalities in the connectivity of right temporal 
lobe with the other lobes in the gamma frequency band in children with Asperger 
Syndrome (55).  
 
 
(From: Noroozian M, Sheikhani A, Behnam H, Mohammadi MR. Abnormalities of Quantitative 
Electroencephalography in Children with Asperger Disorder Using Spectrogram and Coherence 
Values. Iran J Psychiatry 2008; p 68) (55) 
Fig. 2. Results of connectivity in 171 pairs of electrodes that had significant differences in 
frequency bands, Significantly differences with p<0.05 in two groups control subjects and 
Asperger disorder shown with dot lines and with p<0.01 shown with solid lines, a) alpha, b) 
beta and c) gamma frequency band. 
In another study, a chaos theory was used to introduce a neural network model for EEG-
based assessment of ASD ,and it appraised a precision of 90% (56).   
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5. Pharmacological therapy of ASDs 
Although there is no strong evidence of dopamine involvement in autism, neuroleptics have 
been used for a long time to decrease aggressive behaviors, stereotypic behaviors, and 
impulsivity. Low-potency neuroleptics were soon abandoned due to their cognitive and 
sedative side effects. Among high-potency neuroleptics, haloperidol has been studied the 
most. Several controlled studies showed benefits over placebo among young children 
treated with dosages in the range of 1 to 2 mg daily to improve attention and to reduce 
hyperactivity, anger outbursts, and stereotypes (57, 58). However, problematic side effects 
in the form of acute dystonic reactions, withdrawal dyskinesias, and tardive dyskinesias 
were noted. Typical neuroleptics have been replaced with atypical antipsychotics that 
combine dopamine (D2) and serotonin (5-HT2) receptor antagonist actions (57-60). 
Following several open-label studies suggesting the efficacy of risperidone, a 12-week, 
double-blind, placebo-controlled trial was conducted with 31 adults (mean age 28 years) 
with autism and PDD NOS. Significantly, at a mean dosage of 2.9 mg daily, more 
responders (57% vs. 0%) were found in the risperidone than in the placebo group, and 
improvements were noted for irritability, anxiety or nervousness, aggression, repetitive 
behaviors, and depression. There were no improvements on objective measurements of 
social behavior and language, suggesting that the drug targets nonspecific behavioral 
problems associated with autism (61, 62). The drug was well tolerated. More recently, a 
multicentric, 8-week, double- blind, placebo-controlled trial of risperidone (dosage range 0.5 
to 3.5 mg daily) was completed on 101 children with autism aged 5 to 17 years (mean age 8.8 
years) presenting with clinical levels of tantrums, aggression, and self-injurious behavior. 
Significant benefits of the active medication were observed for the 2 primary outcome 
measures of reduced irritability scores (57% vs. 14%) and a rating of “much improved” or 
“very much improved” on a Clinical Global Improvement (CGI) scale (69% vs. 12%). Side 
effects such as fatigue, drowsiness, increased appetite, and drooling were more common in 
the risperidone group, as was a significantly higher weight gain (2.7 vs. 0.8 kgs). Promising 
open label studies have been conducted with olanzapine, quetiapine, clozapine, and 
ziprasidone. Several randomized studies are also under way. Atypical neuroleptics, 
therefore, appear to be promising agents in treating those behavioral symptoms which often 
occur among autism patients. Yet, despite their good tolerance, these drugs are associated 
with some undesirable adverse effects, such as tachycardia in young children taking 
risperidone and sedation for all atypicals, the most serious of which is substantial weight 
gain. There are no long-term studies of the drugs’ efficacy and tolerability (60-64). 
Several pharmacological interventions for children with ASDs have been performed in Iran. 
Akhondzadeh  et al. (2010) administered a 10-week double-blind placebo-controlled trial to 
access the effects of pentoxifylline added to risperidone in comparison with placebo plus 
risperidone in the treatment of autistic disorder. The dose of risperidone was assayed up to 
3 mg/day, and pentoxifylline was assayed 600 mg/day. The Aberrant Behavior Checklist-
Community Rating Scale indicated lower scores for Irritability, Lethargy/Social 
Withdrawal, Stereotyped Behavior, Hyperactivity/Noncompliance and Inappropriate 
Speech in autistic children who used pentoxifylline plus risperidone as compared to the 
other group (65). In another study, Akhondzadeh examined the efficacy of piracetam added 
to risperidone in autistic disorder in a 10-week study. The dose of risperidone was assayed 
up to 2 mg/day for children between 10 and 40 kg and 3 mg/day for children weighting 
above 40 kg. The dose of piracetam was assayed up to 800 mg/day. The scores comparison 
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of the Aberrant Behavior Checklist-Community Rating Scale between the autistic children 
who had received piracetam plus risperidone and the group who had received placebo plus 
risperidone in the baseline and week 10 revealed that a combination of atypical 
antipsychotic medications and a glutamate agent such as piracetam may increase synergistic 
effects in the treatment of autism (66). In addition, combination of topiramate with 
risperidone demonstrated reduced scores for irritability, stereotypic behavior and 
hyperactivity/noncompliance in comparison with using placebo plus risperidone in autistic 
children. In this 8-week, double-blind, placebo-controlled study, the dose of risperidone was 
assayed up to 2 mg/day for children between 10 and 40 kg and 3 mg/day for children 
weighting above 40 kg. The dose of topiramate was assayed up to 200 mg/day for children 
weighting above 40 kg, and 100 mg/day for children weighting less than 30 kg (67). In 
another double-blind placebo-controlled trial, cyproheptadine as a 5-HT2 antagonist plus 
haloperidol was evaluated in the treatment of autistic disorder. The results suggested that 
the combination of cyproheptadine with a conventional antipsychotic may be more effective 
than conventional antipsychotic alone for autistic children (68). In comparison of celecoxib 
added to risperidone with risperidone plus placebo, significant differences were observed 
between the two groups and the results showed reduced scores for Irritability, Lethargy and 
Stereotyped behavior in autistic children who used celecoxib plus risperidone (69). 
Ghanizadeh (2011) hypothesized that Glycine site on the N-methyl-D: -aspartic acid 
(NMDA) glutamate receptor can be tested as a new strategy for the treatment of autism (70). 
He also introduced neurotensin as a novel approach to  treat autism (71).  
6. Behavioral and social therapies of ASDs 
There are various intervention approaches for training children with ASDs. For instance, 
Applied Behavioral Analysis (ABA), Eclectic-Developmental (ED), Training and Education 
of Autistic and other Communication Handicapped Children (TEACCH), Picture Exchange 
Communication System (PECS), Learning Experiences and Alternative Program for 
Preschoolers and Their Parents (LEAP), and Early Intensive Behavioral Intervention (EIBI). 
Several studies indicated that these behavioral and social interventions can improve non-
verbal IQ, expressive IQ, receptive language, adaptive behavior, verbal cognitive abilities, 
socialization, communication adaptive skills, reciprocal social interaction, intellectual and 
educational gains in children with ASDs   (72-80). 
Applied Behavioral Analysis is a science that utilizes operant conditioning principles to 
increase desirable behaviors and decrease problematic behaviors; accordingly, reinforcement 
and punishment can be used to train individuals with ASDs. In ABA approach, firstly the 
baseline levels of target behaviors in individuals with ASDs should be operationally defined 
and measured; assessment instruments such as Vineland Adaptive Behavior Scale, AAIDD 
Adaptive Behavior Scale- School: Second Edition (ABS-S: 2) and Developmental Behavior 
Checklist (DBC) can be used to evaluate children abilities in different domains. Then, ABA 
intervention method is performed to alter target behaviors and finally, the rate of changing 
behavior can be revealed in the repeated measurement (81-85)   
In Iran, home based lovaas approach was performed for treating autism, and the results 
showed that it was effective to improve social interaction, speech and language, play and 
behavior skills in autistic children (86). Furthermore, the effect of Applied Behavior Analysis 
(ABA) intervention method was demonstrated on autistic children who had acquired 
significant improvements in suitable behaviors (87). In another research, three therapeutic 
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interventions (drug, education and combined therapy) were administered to autistic 
children. The results showed that while risperidone therapy positively affected  stereotyped 
behavior and hyperactivity, education (according to Lovaas approach) improved social 
communication and language development of autistic children (88). The effectiveness of 
parent-child interaction therapy was investigated in four young children with high 
functioning autism, and the result showed a decrease in their behavioral problems (89). In 
another study, social stories as a social skills training was evaluated in autistic children, and 
the results indicated that this intervention was effective to decrease autistic behavior and 
improve social development in autistic children (90).    
7. Mental health of ASDs mothers 
Since it seems that parents of children with ASDs experience some stresses such as stigma, 
blame and insufficient social support in developing countries (91, 92), several studies have 
been conducted to investigate parental problems, especially in mothers, in Iran. A scientific 
research indicated a significant difference in parenting stress and coping strategies (emotion 
focused and problem-focused) variables between mothers with autistic children and 
mothers who had normal children ; also a significant correlation was observed between 
stress levels and emotion-focused coping strategies in mothers with autistic children (93). 
Another study investigated personality characteristics and attachment style in mothers with 
autistic children in comparison with mothers who had normal children. This study showed 
a significant difference in Neuroticism versus Emotional stability, not other characteristics. 
Also no significant difference was observed in the attachment style between the two groups. 
Based on the results, while mothers with autistic children could be in the Neurotic group, 
mothers with normal children were almost in the emotionally stable group (94). The 
correlation between personality characteristics and coping strategies was studied in parents 
who had children with ASDs; the study indicated no significant difference in coping 
strategies between fathers and mothers of children with ASDs. However, original thinking, 
sociability and vigor characteristics were significantly different between them (95). In 
another study, parental stress was compared in mothers of autistic children with mothers 
who had normal children, and the results indicated higher scores of parental stress for 
mothers of autistic children (96). The results of another investigation showed that 27.5% of 
the mothers with autistic children had mental disorders, and a significant correlation was 
observed between insufficient coping strategies and mental health (97).      
Some interventions were performed to reduce mental problems in mothers with autistic 
children. A preliminary investigation showed that the symptoms of stress, depression, and 
anxiety of mothers with autistic children were relatively reduced by guided imagery via 
music (98). In another study, the group counseling was administered to a group of mothers 
with autistic children and the results indicated significant differences in the family 
performance and marital satisfaction scores in mothers who had received group counseling 
compared to control group (99).   
8. Summary  
The first preliminary study to investigate the frequency of ASDs in university students was 
conducted by Nejatisafa (2003); while the scores were significantly higher for men than 
women, the results showed the frequency of 120 out of 1000 adult participants (35).  
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In school children, the rate of 19 per 1000 for autistic disorder and 5 per 1000 for Asperger 
syndrome seem more than the reported ASDs prevalence in developed countries. In this 
clinical study, no significant correlation was observed between gender and age, diagnosis 
and severity of the symptoms in ASDs children. The research indicated the brain stem 
abnormality in severe autistic children which may result in intensifying the autism 
symptoms. Social interaction and stereotyped behaviors were investigated between 
autistic and MR children. The results showed higher mean scores of qualitative damage to 
social interaction and stereotyped behaviors in autistic children compared to MR children.  
We diagnosed ASDs children using qEEG in comparison with normal children. 
Considering that the relaxed eye-opened condition in alpha band was the best condition 
to discriminate between children with ASDs and normal group, the ASDs had significant 
lower spectrogram criteria values (p<0.01) at Fp1, Fp2, F3 and T5 electrodes and lower 
values (p<0.05) at T3, P3 and O1 electrodes. Spectrogram criteria had displayed more 
abnormalities in the left brain hemisphere and prefrontal lobe in children with ASDs. 
Magnitude Squared Coherence values at 171 pairs of EEG electrodes in the relaxed eye-
opened condition illustrated more abnormalities in the connectivity of temporal lobes 
with other lobes in gamma frequency band in children with ASDs. It should be noted that 
one study pointed the gamma frequency band as the best discriminant in children with 
Asperger compared to the normal group. Asperger children had significant lower 
spectrogram criteria values (p<0.01) at Fp1 electrode, and lower values (p<0.05) at Fp2 
and T6 electrodes. Coherence values at 171 pairs of EEG electrodes displayed the 
connectivity at (T4, P4), (T4, Cz), (T4, C4) electrode pairs and (T4, O1) had significant 
differences (p<0.01) in the two groups in the gamma band. The prefrontal and right 
temporal lobes had more abnormalities based on using spectrogram, and coherence 
values showed more abnormalities in the connectivity of right temporal lobe with the 
other lobes in the gamma frequency band in Asperger children. 
In pharmacotherapy, typical antipsychotics have been replaced with atypicals that combine 
dopamine and serotonin receptor antagonist. The effects of pentoxifylline added to 
risperidone in comparison with placebo plus risperidone in the treatment of autistic 
disorder. The Aberrant Behavior Checklist Community Rating Scale indicated lower scores 
for irritability, lethargy, social withdrawal, stereotyped behavior, hyperactivity, 
noncompliance and inappropriate speech in autistic children who used pentoxifylline plus 
risperidone.  Autistic children who received piracetam plus risperidone might have 
experienced synergistic effects of medications. Topiramate with risperidone demonstrated 
reduced scores for irritability, stereotypic behavior, hyperactivity and noncompliance in 
comparison with using placebo plus risperidone in autistic children. Combination of 
celecoxib with risperidone in comparison with risperidone plus placebo, caused significant 
differences between the two groups and the results showed reduced scores for irritability, 
lethargy and stereotyped behaviors in autistic children. 
In Iran, home based lovaas approach was performed for the treatment of ASDs, and the 
results showed that it was effective in improving the social relationships, speech and 
language, play and behavior skills in PDD children. The effect of ABA intervention was 
demonstrated in autistic children who had acquired significant improvements in behaviors. 
The results of another investigation showed that 27.5% of the mothers with autistic children 
had mental disorders, and a significant correlation was observed between insufficient 
coping strategies and mental health. 
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It seems that Autism Spectrum Disorders are unknown in developing and developed 
countries and parents who have children with ASDs suffer from lack of social support. 
Although several studies have been conducted on ASDs in Iran, still they are not sufficient, 
especially in ASDs epidemiology and etiology. Because of the essential role of cultural 
factors in better understanding and improvement of ASDs, more comprehensive researches 
in prevalence, etiology, diagnosis and treatment of ASDs should be performed in many 
countries including Iran.  
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